Evidence map›Paper›PMID 29604330›Full record

ReviewMolecular and cellular neurosciences2018

Metabotropic glutamate receptor trafficking.

Young Ho Suh, Kai Chang, Katherine W Roche

Abstract readReview
In one paragraph

Review in Molecular and cellular neurosciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 54 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Review
  8. Control of G protein-coupled receptor function via membrane-interacting intrinsically disordered C-terminal domains.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. The PrLiScience · 2023
    Article
  13. Article
  14. Review
  15. Attention-deficit/hyperactive disorder updates.Frontiers in molecular neuroscience · 2022
    Review
  16. Review
  17. Article
  18. Article
  19. PathogenicThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 3 countries.

Young Ho SuhDepartment of Biomedical Sciences, Neuroscience Research Institute, Seoul National University College of Medicine, Seoul 03080, South Korea. Electronic address: suhyho@snu.ac.kr.
Kai ChangReceptor Biology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA.
Katherine W RocheReceptor Biology Section, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: rochek@ninds.nih.gov.
National Institutes of Health · USSeoul National University · KR

Funding

Subunit-Specific Regulation Of Glutamate ReceptorsZ01NS002994 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI ROCHE, KATHERINE W · 2002 to 2008
$2.8M
Intramural NIH HHS Z01 NS002994
6 · The paper itself

Abstract

The metabotropic glutamate receptors (mGlu receptors) are G protein-coupled receptors that bind to the excitatory neurotransmitter glutamate and are important in the modulation of neuronal excitability, synaptic transmission, and plasticity in the central nervous system. Trafficking of mGlu receptors in and out of the synaptic plasma membrane is a fundamental mechanism modulating excitatory synaptic function through regulation of receptor abundance, desensitization, and signaling profiles. In this review, we cover the regulatory mechanisms determining surface expression and endocytosis of mGlu receptors, with particular focus on post-translational modifications and receptor-protein interactions. The literature we review broadens our insight into the precise events defining the expression of functional mGlu receptors at synapses, and will likely contribute to the successful development of novel therapeutic targets for a variety of developmental, neurological, and psychiatric disorders.

Indexed as

AnimalsHumansNeuronsProtein Processing, Post-TranslationalProtein TransportReceptors, Metabotropic GlutamateReceptors, Metabotropic GlutamateEndocytosisMetabotropic glutamate receptorsPhosphorylationPost-translational modificationProtein-protein interactionTrafficking

Identifiers

PMID29604330
PMCPMC6128748
OpenAlexW2794984074

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.